Back
Grupo Aeroportuario del Centro Norte SAB de CV 10K Form
Buy
58
OMAB
Grupo Aeroportuario del Centro Norte SAB de CV
Last Price:
$72.05
Seasonality Move:
3.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OMAB News And Ratings
See the #1 stock for the next 7 days that we like better than OMAB
OMAB Financial Statistics
Sales & Book Value
Annual Sales: | $816M |
---|---|
Cash Flow: | $-6.8M |
Price / Cash Flow: | 11.33 |
Annual Sales: | $9.70 |
Price / Book: | 7.45 |
Profitability
EPS (TTM): | 5.84370 |
---|---|
Net Income (TTM): | $282.1M |
Gross Margin: | $536.8M |
Return on Equity: | 54.21% |
Return on Assets: | 19.14% |
Grupo Aeroportuario del Centro Norte SAB de CV Earnings Forecast
Key Grupo Aeroportuario del Centro Norte SAB de CV Financial Ratios
-
The Gross Profit Margin over the past 19 years for OMAB is 65.78%.
-
The Selling, General & Administrative Expenses for OMAB have been equal to 4.58% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 25.33% of Operating Income.
-
The Net Earning history of OMAB is 34.67% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 13 years.
Grupo Aeroportuario del Centro Norte SAB de CV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Transportation Infrastructure |
Sector: | Industrials |
Current Symbol: | OMAB |
CUSIP: | 400501 |
Website: | oma.aero |
Debt
Debt-to-Equity Ratio: | 1.16 |
---|---|
Current Ratio: | 1.08 |
Quick Ratio: | 0.98 |
Price-to-Earnings
Trailing P/E Ratio: | 12.32 |
---|---|
Forward P/E Ratio: | 12.29 |
OMAB Technical Analysis vs Fundamental Analysis
Buy
58
Grupo Aeroportuario del Centro Norte SAB de CV (OMAB)
is a Buy
Is Grupo Aeroportuario del Centro Norte SAB de CV a Buy or a Sell?
-
Grupo Aeroportuario del Centro Norte SAB de CV stock is rated a BuyThe current Grupo Aeroportuario del Centro Norte SAB de CV [OMAB] share price is $72.22. The Score for OMAB is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.